Uzbekistan
Jurabek Laboratories Ltd is a prominent pharmaceutical manufacturer headquartered in Uzbekistan, established in 1996. The company has become a leader in the region through its adherence to International Standards of Good Manufacturing Practice (GMP), ensuring high-quality production of pharmaceuticals across various types and dosages.
The company's notable achievements include the 2004 launch of a unique workshop dedicated to cephalosporin antibiotics, securing a significant market portion in Uzbekistan. By 2007, Jurabek Laboratories Ltd expanded its offerings with a new facility for dry powder antibiotics, fortifying its leadership in broad-spectrum antibiotics.
Furthermore, the company's investment in 2008 resulted in the creation of a state-of-the-art facility producing infusion solutions in polypropylene vials. This move, financed by the European Bank of Reconstruction and Development, highlights Jurabek Laboratories Ltd's commitment to innovation and market leadership. Despite its achievements, the company has no recent investment activities, suggesting potential for strategic financial partnerships to fuel further growth.
